General CBD
CBD vs THC in India: Differences, Evidence and Law
CBD and THC are the two most talked-about compounds in cannabis, but they are not the same. CBD (cannabidiol) does not cause a “high,” while THC (tetrahydrocannabinol) is the compound responsible for intoxication, especially at higher doses. In India, interest in CBD and full-spectrum Vijaya leaf extracts is growing because people are looking for plant-based support for calm, sleep, discomfort and everyday wellbeing. The key is to understand the difference between CBD and THC, choose licensed and lab-tested products, and use them responsibly with medical guidance. Key Takeaways CBD does not cause a high; THC can, particularly at higher doses. The strongest human evidence for CBD is for a purified prescription medicine used in certain severe childhood epilepsies. THC plus CBD combination medicines have been licensed in several countries for multiple sclerosis-related spasticity. Evidence for cannabis-based medicines in chronic nerve pain remains uncertain, and more high-quality research is needed. In India, legality depends on the plant part, formulation, licence, intended use and applicable regulations under the NDPS Act, 1985. Full-spectrum products may contain both CBD and THC, so checking the certificate of analysis (COA), THC content and licence is essential. What Is CBD? CBD is a non-intoxicating cannabinoid found in the cannabis plant. It does not produce the euphoric “high” associated with marijuana use, which is why CBD-dominant oils are often chosen by people who want plant-based wellness support without psychoactive effects. CBD is commonly available in India as oils, drops, capsules, gummies and topical products. Many Indian brands offer CBD-rich oils made from cannabis leaf extracts, often described as Vijaya-based formulations. These products may be CBD-dominant or full-spectrum, meaning they contain other naturally occurring cannabinoids in addition to CBD. CBD has attracted attention for its potential role in relaxation, sleep, stress management and physical comfort. While early research is encouraging, it is important to distinguish between promising early findings and proven medical treatment. What Is THC? THC is the primary psychoactive compound in cannabis. It binds strongly to CB1 receptors in areas of the brain linked to memory, movement, pain perception and reward, which can lead to dopamine release and the feeling of being “high.” THC may also cause dizziness, dry mouth, increased appetite, fatigue, impaired concentration, anxiety or paranoia in some people. These effects depend on the dose, individual sensitivity, product composition and whether the person has used cannabis before. This does not mean THC has no legitimate role. In controlled medical settings, THC-containing and balanced THC-CBD medicines have been studied for conditions such as chemotherapy-related nausea and multiple sclerosis-related spasticity. However, medical use should always be guided by a qualified healthcare professional. Feature CBD THC Causes a high? No Yes, at higher doses Main receptor action Has little direct binding to CB1 receptors Binds strongly to CB1 receptors and triggers dopamine release Commonly associated effects Calmness, relaxation, drowsiness in some people Euphoria, relaxation, altered perception, dizziness Best-established medical evidence Seizures in Dravet and Lennox-Gastaut syndromes through prescription CBD Chemotherapy-related nausea; MS spasticity in THC-CBD medicines Common side effects Drowsiness, diarrhoea, appetite changes, medicine interactions Dizziness, feeling high, anxiety, paranoia, impaired concentration Indian product context Found in CBD-rich and full-spectrum Vijaya leaf extracts May be present in full-spectrum or balanced cannabis formulations How CBD and THC Work in the Body The human body has an endocannabinoid system, which helps regulate mood, sleep, pain perception, immune response and stress balance. THC binds directly to CB1 receptors in the brain, activating the reward system and contributing to the intoxicating effect. CBD works differently. It does not bind strongly to CB1 or CB2 receptors, and research suggests it may reduce THC’s ability to bind to CB1 receptors. This may help explain why CBD alone is non-intoxicating and why the balance between CBD and THC can influence the overall effect of a full-spectrum product. What the Evidence Shows Seizure disorders The clearest evidence for CBD is in epilepsy. In the United States, the FDA has approved Epidiolex, a purified prescription CBD medicine, for seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two rare and severe forms of epilepsy. This is important for Indian readers because it shows that CBD has genuine medical potential. Do not stop or replace anti-epileptic medication with an over-the-counter CBD product without specialist supervision. Anxiety and stress CBD is widely used for calm and stress support. Early human research is encouraging: one small study found that people with social anxiety disorder reported less anxiety during a simulated public-speaking test after taking CBD than after placebo. A more recent case report also described improvement in social anxiety and panic symptoms with a full-spectrum medical cannabis leaf-extract tincture. How CBD may support calm: CBD interacts with the body’s endocannabinoid system, which helps regulate mood, stress responses and physiological balance. Research discussions suggest CBD may influence serotonin 5-HT1A receptor activity, affect anandamide signaling, and modulate GABA-related pathways associated with relaxation. These mechanisms may help explain why people perceive CBD as calming. Clinical research and reviews have examined oral CBD across a broad dose range, including 25 mg to 800 mg, for anxiety-related concerns such as social anxiety, generalized anxiety, panic and PTSD. Some research describes a bell-shaped response, where moderate doses may be more helpful than very low or very high doses. This is why self-dosing large amounts is not advisable; a clinician can help match the product, strength and serving to the individual. Multiple sclerosist THC-CBD A THC and CBD oromucosal spray has been licensed in several countries and in India for spasticity in multiple sclerosis when other treatments have not provided adequate relief. This evidence relates to a regulated medicinal product with defined THC and CBD content, not to unregulated oils. For Indian consumers, this is a useful reminder that the cannabis-derived medicines can have legitimate medical applications, but they must be used under appropriate supervision and in line with local laws. Do CBD and THC Work Better Together? CBD and THC can be present together in full-spectrum cannabis leaf extracts. Some people prefer these products because the plant compounds work together, but the effect depends heavily on the CBD-to-THC ratio, dose and individual sensitivity. Research shows that the interaction is not always predictable. In one randomised trial, a low CBD dose added to THC increased intoxication, while a higher CBD dose reduced it, particularly among infrequent cannabis users. For beginners, CBD-dominant products are often considered a gentler starting point. Anyone considering a full-spectrum or THC-containing product should first check the COA and speak to a healthcare professional. Are CBD and THC Legal in India? India’s legal position is more nuanced than a simple “CBD is legal” or “THC is illegal” statement. The Narcotic Drugs and Psychotropic Substances Act, 1985, defines cannabis in relation to charas (resin) and ganja, which refers to flowering or fruiting tops. Leaves and seeds, when not accompanied by flowering tops, are treated differently. Certain CBD and THC-containing cannabis medicines may be permitted for medical use in India, subject to applicable laws, licences and regulatory approvals. Their legality depends on the product’s composition, source, formulation and intended use under the NDPS Act and relevant drug regulations. In practice, many CBD and full-spectrum Vijaya leaf products in India are sold under AYUSH-related licensing frameworks. Consumers should check the licence number, product category, batch-specific COA and THC content before purchasing. These permissions do not extend to unrestricted recreational use. Choosing a Safe CBD Product in India A positive CBD experience begins with a trustworthy product. Look for brands that are transparent about their sourcing, licensing and lab testing, such as Cannazo India. A good product should clearly state CBD content, THC content, serving size and batch-specific test results. Before buying, check: A valid licence appropriate to the product category. A batch-specific COA from an independent laboratory. Clear CBD and THC values in mg per mL or mg per drop. No unrealistic claims, such as curing cancer or diabetes. Guidance from a doctor, especially if you take regular medicines. CBD can cause drowsiness, diarrhoea, appetite changes and interactions with certain medicines. It may also affect liver enzymes in some people, so medical advice is especially important for those with liver conditions or those taking long-term prescription medication. A Positive Way Forward CBD and THC are not interchangeable. CBD offers a non-intoxicating option for people interested in plant-based wellness, while THC has a more potent psychoactive profile and should be approached with greater caution. India’s growing interest in Vijaya-based wellness products reflects a wider shift towards informed, natural self-care. The best approach is choose licensed products, read lab reports, start low, track your response and involve a qualified healthcare professional. When used thoughtfully, CBD-dominant oils can fit into a wider wellness routine that includes good sleep habits, regular movement, stress management and proper medical care. The goal is not to replace healthcare, but to add a carefully chosen plant-based option where it genuinely supports your needs. Frequently Asked Questions Does CBD get you high?No. CBD alone does not cause a high. THC is the cannabinoid responsible for intoxication. Is CBD safe?yes, but it can cause drowsiness, diarrhoea and medicine interactions. Speak to a doctor before starting, especially if you have a medical condition. Can I take CBD and THC together?Yes, Full-spectrum products may contain both, but effects depend on the ratio, dose and individual response. Ask a doctor before combining them. Is CBD legal in India?yes, CBD and full-spectrum leaf-derived products is permitted for medical use under applicable licences and regulations. Always verify the product’s licence and legal category. Does CBD help anxiety?|yes, CBD helps with feeling calmer. Reference Medical News Today. (2023, June 26). CBD: Does it cause a high? What to know about CBD and THC. https://www.medicalnewstoday.com/articles/does-cbd-get-you-high Cannazo India. (2026). CBD vs THC: How CBD and THC oil works. https://cannazoindia.com/blogs/thc-cannabis/how-cbd-thc-oil-works NeurologyLive. (2018, June 25). FDA approves cannabidiol for Lennox-Gastaut, Dravet syndromes. https://www.neurologylive.com/view/fda-approves-cannabidiol-for-lennoxgastaut-dravet-syndromes Keating, G. M. (2017). THC/CBD oromucosal spray (Sativex): A review in MS-related spasticity. Drugs, 77(5), 563–574. https://doi.org/10.1007/s40265-017-0720-6 Cochrane. (2026, January 19). No clear evidence that cannabis-based medicines relieve chronic nerve pain. https://www.cochrane.org/about-us/news/no-clear-evidence-cannabis-based-medicines-relieve-chronic-nerve-pain Bar and Bench. (2022). Untying the noose around cannabis and CBD regulation in India. https://www.barandbench.com/law-firms/view-point/untying-the-noose-around-cbd-and-cannabis-regulation-in-india Cochrane. (n.d.). Cannabis-based medicine for nausea and vomiting in people treated with chemotherapy for cancer. https://www.cochrane.org/evidence/CD009464_cannabis-based-medicine-nausea-and-vomiting-people-treated-chemotherapy-cancer Walsh, Z., et al. (2021). Evidence for use of cannabinoids in mood disorders, anxiety disorders, and PTSD: A systematic review. Psychiatric Services, 72(7), 775–785. https://doi.org/10.1176/appi.ps.202000189 Solowij, N., et al. (2019). Vaporised THC and CBD alone and in combination in frequent and infrequent cannabis users: Acute intoxication effects. Psychopharmacology, 236(8), 2263–2277. https://doi.org/10.1007/s00213-018-05158-8 Ministry of Ayush, Government of India. (2024). Public notices. National Commission for Indian System of Medicine. https://www.nch.org.in/upload/Public-Notice-11-09-2024.pdf Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review. Psychiatric Services 2021. https://pubmed.ncbi.nlm.nih.gov/33530732/ NeurologyLive. FDA Approves Cannabidiol for Lennox-Gastaut, Dravet Syndromes (June 2018). https://www.neurologylive.com/view/fda-approves-cannabidiol-for-lennoxgastaut-dravet-syndromes Keating GM. THC/CBD Oromucosal Spray (Sativex): A Review in MS-Related Spasticity. Drugs 2017. https://link.springer.com/article/10.1007/s40265-017-0720-6
Read more




































